Irritable bowel syndrome (IBS) is one of the most prevalent functional gastrointestinal disorders (FGID), affecting approximately 14% of the global population (Werlang, Palmer, & Lacy, 2019). UK NICE guidelines diagnose Individuals with IBS after having the presence of abdominal discomfort or pain either associated with defaecation and/or accompanied by a change in bowel habit. Individuals with IBS present with varying symptom profiles, most commonly 'diarrhoea predominant',